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To the Editor: To get ready for the spread of chi-
kungunya, health authorities in North, South, and Central 
America and the Pacific Islands are developing prepared-
ness and response plans (1,2) that contain vector control, 
epidemiologic surveillance, medical education, and com-
munication components. They might consider the experi-
ence of Réunion Island, an overseas department of France, 
where a chikungunya outbreak affected 38.5% of its 
800,000 inhabitants during the first 3 months of 2006 (3). 
Although the island was unprepared to deal with such a 
massive outbreak (4), the disease was under control by the 
middle of 2006; only a few sporadic cases occurred dur-
ing the following years. In addition to taking recommended 
public health measures, public health officials in France 
created a task force with physicians (including intensive 
care unit doctors, pediatricians, and obstetricians), special-
ists in public health and social sciences, virologists, immu-
nologists, entomologists, and pathologists (5) to develop a 
multidisciplinary approach to the outbreak.
Some citizens’ initiatives complemented the official 
measures. First, associations of chikungunya virus–infected 
patients helped families (through means that included psy-
chological and friendly support and home visits) and updated 
mass media with regard to disease complications, persistent 
symptoms, and administrative difficulties (including receiv-
ing long-term sick leave and disability, recognition of profes-
sional exposure, and free analgesic medication). Second, cit-
izens created a chikungunya-dedicated website (http://www.
chikungunya.net) that included citizens’ frequently asked 
questions and university-affiliated physicians’ responses 
and patients’ forums. Third, citizens actively supported the 
twice-yearly Kass moustik (Creole for “to break mosqui-
toes”) operations, which involved vast community mobili-
zations to educate persons on mosquitoes’ role in spreading 
chikungunya and to destroy breeding sites near homes. The 
operations also involved mobilizing community-based and 
municipality groups, making door-to-door visits, and lobby-
ing for government funds (each operation cost US $60,000). 
After implementation of these initiatives, telephone operators 
sent health messages to all cell phones on the island. These 
actions demonstrate that citizens have a place in their coun-
tries’ response to chikungunya outbreaks.
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To the Editor: Loa loa, the African eye worm, is a 
filarial pathogen of Central African rainforest regions. As 
of 2013, it had affected an estimated 2–3 million persons 
in Central Africa (1,2). Adult worm migrations in humans 
may intermittently cause Calabar swelling, and microfilar-
iae are commonly found in blood and body fluids. Loiasis 
is a chronic infection persisting for many years; a consider-
able proportion of women in loiasis-endemic regions are 
infected during gestation. To date, the epidemiology of lo-
iasis in pregnant women has not been investigated, and the 
effects of loiasis on maternal and fetal health outcomes are 
unknown. We investigated the epidemiology of loiasis in a 
cohort of pregnant women participating in a drug trial for 
preventing malaria during pregnancy.
This study was conducted at the Centre de Recherch-
es Médicales de Lambaréné, Albert Schweitzer Hospital, 
Lambaréné, Gabon, and at the Ngounié Medical Research 
Centre, Fougamou, Gabon, during September 2009–April 
2012 (3). The filarial pathogens L. loa and Mansonella per-
stans are endemic to the study region, which is in the equa-
torial rainforest, and malaria is hyperendemic in the re-
gion (1,4). Study participants were HIV-negative pregnant 
women in a clinical trial assessing intermittent preventive 
treatment of malaria during pregnancy (clinical trials iden-
tifier: Malaria in Pregnancy Preventive Alternative Drugs 
[MiPPAD]; NCT00811421) (5). Pregnant women were re-
cruited before their third trimester. After providing written 
informed consent, they were randomly allocated to receive 
treatment with either sulfadoxine/pyrimethamine or me-
floquine. Ethical clearance was obtained from the Comité 
d’Ethique Regional Indépendent de Lambaréné.
Women for whom >1 microscopic examination of 
blood revealed microfilariae during the course of their 
pregnancy were classified as L. loa infected. Women were 
considered afilaremic if >2 blood examination results were 
negative. Microfilariae were detected by examination of 
thick and thin blood smears or by saponin leukoconcen-
tration. Examination for placental infection was performed 
by impression smear of a fresh placental biopsy. Baseline 
demographic and anthropometric characteristics were re-
corded at the first antenatal visit and at delivery. Data were 
double-entered into an electronic database for statistical 
analysis (STATA/SE 12.1; StataCorp LP, College Station, 
TX, USA).
Of 1,184 women participating in the antimalarial drug 
trial, 1,004 contributed data for our analysis. Women who 
had no record of delivery (n = 120) or who had multiple 
births (n = 60) were excluded. Of these 1,004 women, L. 
loa microfilariae were found in peripheral blood of 179 
(18%); of those, microfilariae were found in placental blood 
of 24 (13%). No microfilariae were found in the placenta 
of women with amicrofilaremic peripheral blood. Loiasis 
prevalence was higher among older women (>30 years of 
age) than among adolescents (14–17 years of age; odds ra-
tio 2.1, 95% CI 1.2–3.9). Microfilaremia was more com-
mon among multigravid women than among primigravid 
women (p = 0.06) but was not associated with other mater-
nal baseline characteristics or with low infant birthweight, 
preterm births, or adverse delivery outcomes (Table). No 
histologic evidence of intervillous inflammation, infarcted 
areas, or chorioamnionitis was observed in the placenta of 
women with loiasis, and no microfilariae were observed in 
any examined cord blood samples.
In this study, we attempted to characterize the epide-
miology of L. loa infection during pregnancy in a highly L. 
loa–endemic region of Central Africa. Microfilaremia was 
associated with the women’s age, a finding indicating that 
prevalence increases because of the long duration of infec-
tion and continued exposure. The age-related increase in 
the prevalence of L. loa infection aligns with previously 
reported prevalence and contrasts with age-related preva-
lence of other parasitic infections (6,7). Anecdotal evi-
dence suggests the potential of L. loa worms to invade the 
placenta (8). In this systematic investigation, microfilarial 
invasion of the placenta occurred in 13% of microfilare-
mic patients. However, histopathologic analysis showed no 
evidence for pathologic alterations of the placenta, and risk 
for adverse birth outcomes did not increase. Transgression 
of microfilariae into cord blood was not observed.
This study has limitations. First, misclassification of 
occult infection is possible because infection status was 
classified on the basis of the presence of microfilaremia. 
Also, antimalarial drugs routinely administered during 
pregnancy may have influenced the course of loiasis, as has 
been shown for other helminth infections (9,10). Further, 
the observational study design creates difficulties in estab-
lishing a causal relationship between infection status and 
birth outcomes because of possible confounding factors. 
Additional research is needed to disentangle the association 
among pregnancy outcomes, socioeconomic conditions, 
and pathophysiologic consequences of L. loa infection in 
pregnant women.
Results of this prospective study show a high preva-
lence of loiasis among pregnant women in a loiasis-endem-
ic region in Central Africa. The invasion of microfilariae 
into the intervillous space of the placenta is a newly de-
scribed feature of pregnancy-associated loiasis. These data 
can be used as a starting point for further epidemiologic 
and clinical research activities investigating this neglected 
filarial infection in pregnant women in Central Africa.
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Table. Baseline	characteristics	of	microfilaremic	and	amicrofilaremic	pregnant	women,	Gabon,	September	2009–April	2012 
Characteristic 
Microfilaremic,	no.	(%), 
n	=	179 
Amicrofilaremic,	no.	(%),	 
n	=	825 p	value*	 
Age,	y,	n	=	1,004   0.156 
14–17 17	(9.5) 129	(15.6)  
 18–20 43	(24.0) 191	(23.2)  
 21–24 40	(22.3) 168	(20.4)  
 25–30 34	(19.0) 175	(21.2)  
 31–49 45	(25.1) 162	(19.6)  
Gravidity,	n	=	1,004   0.057 
 First	pregnancy 40	(22.3) 214	(25.9)  
 1–3	previous	pregnancies 73	(40.8) 381	(46.2)  
     >4	previous	pregnancies 66	(36.9) 230	(27.9)  
Literacy,	n	=	1,004   0.151 
 Yes 141	(78.8) 687	(83.3)  
 No 38	(21.2) 138	(16.7)  
Delivery	outcome,	n	=	1,004   0.432 
 Live	birth 172	(96.1) 781	(94.7)  
 Stillbirth	or	abortion 7	(3.9) 44	(5.3)  
Maternal	malarial	infection	at	delivery,	n	=	867†‡   0.453 
 Yes 6	(3.7) 36	(5.1)  
 No 156	(96.3) 669	(94.9)  
Anemia at delivery, hemoglobin <11 g/dL, n = 903†   0.364 
 Yes 77	(46.1) 368 (50.0)  
 No 90	(53.9) 368	(50.0)  
Premature	delivery,	n	=	886†   0.082 
 Yes 14	(8.5) 36	(72.0)  
 No  151	(91.5) 685	(95.0)  
Low	birthweight,	n	=	905†   0.465 
 Yes 24	(14.3) 90	(12.2)  
 No 144	(85.7) 647	(87.8)  
*By	2 test. 
†Maternal	malarial	infection,	anemia,	prematurity,	and	birthweight	were	assessed	for	live	births	only	in	this	analysis. 
‡Low	birthweight	occurred	in	7	(17%)	of	41	babies	born	to	malaria-infected	mothers	compared	with	98	(14%)	of	721	babies	born	to	non–malaria-infected	
mothers. 
 
